Anisodamine hydrobromide is clinically used for the treatment of septic shock, acute gastroenteritis, vertigo, diabetic foot, vascular disorders, various neuralgias, smooth muscle spasms, vestibular vertigo, ocular fundus diseases, sudden sensorineural hearing loss, and organophosphate pesticide poisoning; it acts as an M-cholinoceptor antagonist to relieve microvascular spasm, improve local blood circulation, reduce edema and inflammatory response, and alleviate dizziness, particularly in post-stroke vertigo patients.